Cargando…
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
BACKGROUND: Chronic central serous chorioretinopathy (cCSC) is an eye disease characterized by an accumulation of serous fluid under the retina. It is postulated that this fluid accumulation results from hyperpermeability and swelling of the choroid, the underlying vascular tissue of the eye, causin...
Autores principales: | Breukink, Myrte B., Downes, Susan M., Querques, Giuseppe, van Dijk, Elon H. C., den Hollander, Anneke I., Blanco-Garavito, Rocio, Keunen, Jan E. E., Souied, Eric H., MacLaren, Robert E., Hoyng, Carel B., Fauser, Sascha, Boon, Camiel J. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578347/ https://www.ncbi.nlm.nih.gov/pubmed/26390920 http://dx.doi.org/10.1186/s13063-015-0939-z |
Ejemplares similares
-
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink, Myrte B, et al.
Publicado: (2016) -
Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021) -
Exome sequencing in families with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019) -
Exome sequencing in patients with chronic central serous chorioretinopathy
por: Schellevis, Rosa L., et al.
Publicado: (2019) -
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)